ANTIBODIES AGAINST TISSUE FACTOR PATHWAY INHIBITOR
The invention relates to antibodies that specifically bind to tissue factor pathway inhibitor (TFPI) and that reduce the clotting time of blood. Such antibodies have utility in the treatment of subjects with a coagulopathy.